Catalog |
name |
Description |
price |
R-C-474 |
Enzalutamide (MDV3100) CAS:915087-33-1 |
MDV3100 is androgen-receptor inhibitor.Highly recommended inhibitor in AR research.Enzalutamide(MDV3100) is an androgen-receptor (AR) antagonist with IC50 of 36 nM in LNCaP cells.Enzalutamide is shown to increase autophagy. |
price> |
R-C-517 |
OC000459 cas:851723-84-7 |
Timapiprant (OC000459) is a potent,selective,and orally active D prostanoid receptor 2 (DP2,also known as CRTH2) antagonist.Timapiprant (OC000459)potently displaces [3H] PGD2 from human recombinant DP2(Ki=13 nM),rat recombinant DP2(Ki=3 nM),and human native DP2(Ki=4 nM).Timapiprant (OC000459) inhibits mast cell activation of Th2 lymphocytes and eosinophils. |
price> |
R-C-548 |
DY131 CAS: 95167-41-2 |
DY131(GSK 9089) is a potent and selective ERRγ and ERRβ agonist.DY131displays inactive against ERRα,ERα and ERβ.DY131 also inhibits Smo signaling. |
price> |
R-C-582 |
LY500307 cas:533884-09-2 |
Erteberel(LY500307)is a potent and selective estrogen receptor beta(ERβ)agonist with Ki and EC50 of 1.54 nM and 3.61 nM,respectively.Anti-tumor activities.
|
price> |
R-C-624 |
TAK875 CAS:1000413-72-8 |
Fasiglifam(TAK-875) is a selective GPR40 agonist with EC50 of 14 nM in human GPR40 expressing CHO cell line,400-fold more potent than oleic acid. |
price> |
R-C-636 |
NSC 405020 cas:7497-07-6 |
NSC 405020 is a novel small molecule inhibitor of MT1-MMP that specifically targets PEX domain rather than the catalytic domain of MT1-MMP with IC50 >100 μM and does not inhibit the catalytic activity of MT1-MMP or MMP-2. |
price> |
R-C-646 |
GW9508 cas:885101-89-3 |
GW 9508 is a cell-permeable aminophenylpropanoate that acts as a potent and selective agonist for the G-protein coupled receptor(GPCR)GRP40/FFA1 receptor (EC50 ?50 nM)with reduced activity towards family members GRP120 (EC50?3.5 μM), GRP41/GRP43 (EC50>50 μM),as well as a panel of eight other free fatty acid (FFA) and prostaglandin receptors. |
price> |
R-C-1096 |
UNBS-5162 CAS: 956590-23-1 |
UNBS5162 is a pan-antagonist of CXCL chemokine expression with in vitro cytotoxic activity(IC50 range of 0.5-5 µM)against a range of human cancer cell lines including glioblastoma(Hs683 and U373MG),colorectal(HCT-15 and LoVo), non-small-cell lung(A549)and breast(MCF-7). |
price> |
R-C-1103 |
AL 082D06 CAS:256925-03-8 |
AL082D06 is a nonsteroidal glucocorticoid receptor(GR)antagonist with no detectable binding affinity for the highly related receptors for mineralocorticoids,androgens,estrogens,and progestins. |
price> |
R-C-1140 |
GKT137831 CAS:1218942-37-0 |
GKT137831,a novel pyrazolopyridinedione derivative,a dual inhibitor of NADPH oxidases(NOX)1 and NOX4,reduces inflammation in the ischemic retina by dampening the pro-inflammatory phenotype of retinal immune cells as well as macroglial Müller cells and neurons.GKT137831 may be of significant benefit for patients with systemic sclerosis as studies in experimental models show that the compound may reduce the abnormal growth of connective tissue(fibrosis)and improve survival.GKT-137831 acts as a Nox4 and Nox1 inhibitor((Ki100-150 nM).GKT-137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.Also a potent inhibitor of fibrosis and hepatocyte apoptosis. |
price> |